Disposition and follow-up If a patients hypoglycemia can be attributed to inadequate oral (PO) intake or an inadvertent increase in short-acting or intermediate-acting insulin , the patient is alert , tolerating PO , and clinically stable , and glucose is stable on multiple rechecks, the patient may be discharged
A 2023 pharmacovigilance analysis in the British Journal of Clinical Pharmacology found that GI adverse events, nausea, vomiting, diarrhea, and constipation, accounted for the majority of serious adverse event reports associated with semaglutide in the FDA Adverse Event Reporting System database [2]
51: A309
The key is that these are exceptions, not the new routine
Doxorubicin treatment-related heart damage is a long-term clinical concern, although studies have found that melatonin and empagliflozin may have a heart-protective effect by inhibiting ferroptosis
If you're looking for a place that prioritizes your well-being and drs expert care, this is it